Dawson James Reiterates Buy Rating on Fortress Biotech (FBIO)
Tweet Send to a Friend
Dawson James analyst Jason Kolbert reiterated a Buy rating and $24.00 price target on Fortress Biotech (NASDAQ: FBIO), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


